AVP and type 2 diabetes mellitus: The predictive value of copeptin in identifying NAFLD and NASH in obese individuals was independent from other dysmetabolic conditions, such as increased body adiposity and the diagnosis of T2DM and MS, even if an association between higher copeptin and metabolic impairment was also observed.